drugset / Trial / NCT00351299

Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium

NCT00351299

Phase 2 Completed 53 enrolled Brigham and Women's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the research is to see if dexmedetomidine (a drug that has a calming effect - a sedative) is effective for the treatment of acute delirium

Timeline

Start
2006-01
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified

Indications